Skip to main content


Page 1 of 31

  1. To investigate the efficacy of fertility-preserving treatment for young women with synchronous primary neoplasm of endometrium and ovary.

    Authors: Qujia Gama, Shuhan Luo, Pengfei Wu, Lulu Wang, Sijia Liu, Hongwei Zhang, Li Sun, Yiqin Wang, Min Yu, Xiaojun Chen, Weiwei Shan and Xuezhen Luo
    Citation: Journal of Ovarian Research 2023 16:235
  2. The ovary is an important reproductive organ in mammals, and its development directly affects the sexual maturity and reproductive capacity of individuals. MicroRNAs (miRNAs) are recognized as regulators of re...

    Authors: Yanyan Wang, Jianmin Wang, Qing Li, Rong Xuan, Yanfei Guo, Peipei He and Tianle Chao
    Citation: Journal of Ovarian Research 2023 16:234
  3. Chromobox protein homolog 7 (CBX7), a member of the Polycomb repressor complex, is a potent epigenetic regulator and gene silencer. Our group has previously reported that CBX7 functions as a tumor suppressor i...

    Authors: Yi Zhang, Roslyn Tedja, Michael Millman, Terrence Wong, Alexandra Fox, Hussein Chehade, Meyer Gershater, Nicholas Adzibolosu, Radhika Gogoi, Matthew Anderson, Thomas Rutherford, Zhenggang Zhang, Michael Chopp, Gil Mor and Ayesha B. Alvero
    Citation: Journal of Ovarian Research 2023 16:233
  4. The epithelial-mesenchymal transition (EMT) promotes cell signaling and morphology alterations, contributing to cancer progression. Exosomes, extracellular vesicles containing proteins involved in cell-cell co...

    Authors: Germano Aguiar Ferreira, Carolina Hassibe Thomé, Clarice Izumi, Mariana Lopes Grassi, Guilherme Pauperio Lanfredi, Marcus Smolka, Vitor Marcel Faça and Francisco José Candido dos Reis
    Citation: Journal of Ovarian Research 2023 16:232
  5. Clinical trials are currently exploring combinations of PARP inhibitors and immunotherapies for the treatment of ovarian cancer, but their effects on the ovarian tumour microenvironment (TME) remain unclear. H...

    Authors: Salar Farokhi Boroujeni, Galaxia Rodriguez, Kristianne Galpin, Edward Yakubovich, Humaira Murshed, Dalia Ibrahim, Sara Asif and Barbara C. Vanderhyden
    Citation: Journal of Ovarian Research 2023 16:231
  6. Clinical prediction models play an important role in the field of medicine. These can help predict the probability of an individual suffering from disease, complications, and treatment outcomes by applying spe...

    Authors: Guan Guixue, Pu Yifu, Gao Yuan, Liu Xialei, Shi Fan, Sun Qian, Xu Jinjin, Zhang Linna, Zhang Xiaozuo, Feng Wen and Yang Wen
    Citation: Journal of Ovarian Research 2023 16:230
  7. Inflammation and immunity are two main characteristics of tumor microenvironment (TME). Interferon-gamma (IFN-γ) is generally considered as a pro-inflammatory cytokine which mediates anti-tumor immune response...

    Authors: Hui Zheng, Xiaolin Guan, Xin Meng, Ying Tong, Yanchun Wang, Suhong Xie, Lin Guo and Renquan Lu
    Citation: Journal of Ovarian Research 2023 16:229
  8. The genotype-phenotype relationships between TUBB8 variants and female infertility are difficult to clearly define due to the complex inheritance patterns and the highly heterogeneous phenotypes. This study aims ...

    Authors: Tingwenyi Hu, Chong Li, Sen Qiao, Weiwei Liu, Wei Han, Wei Li, Rong Shi, Xia Xue, Juanzi Shi, Guoning Huang and Tingting Lin
    Citation: Journal of Ovarian Research 2023 16:228
  9. Existing studies have investigated the relationship between the levels of serum inhibin B (INHB), anti-müllerian hormone (AMH) and precocious puberty in girls, but the results are inconsistent.

    Authors: Mei Jiang, Ying Gao, Tiange Qu, Yuechen Ji, Yiwen Niu, Jiaxin Zhang and Ling Huang
    Citation: Journal of Ovarian Research 2023 16:227
  10. The rescue in vitro mature(Rescue IVM) technique allows the use of immature oocytes collected in conventional COH to obtain more mature oocytes for fertilization through in vitro maturation. Some studies have ...

    Authors: Jianbo Wei, Zhongyu Luo, Xiyuan Dong, Huizi Jin, Lixia Zhu and Jihui Ai
    Citation: Journal of Ovarian Research 2023 16:226
  11. The oocyte and its surrounding cumulus cells (CCs) exist as an inseparable entity. The maturation of the oocyte relies on communication between the oocyte and the surrounding CCs. However, oocyte evaluation is...

    Authors: Yena Hu, Ran Zhang, Shuoping Zhang, Yaxing Ji, Qinwei Zhou, Lizhi Leng, Fei Meng, Fei Gong, Guangxiu Lu, Ge Lin and Liang Hu
    Citation: Journal of Ovarian Research 2023 16:225
  12. The influence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on assisted reproductive technology (ART) has received increasing attention. It has been reported that the SARS-CoV-2 Rib...

    Authors: Yuling Mao, Yachao Yao, Hongzi Du, Zheng Wang, Xueliang Zhou, Ming Zeng, Chunyan Wang, Hanyan Liu, Yang Luo, Honghai Hong, Jianqiao Liu and Lei Li
    Citation: Journal of Ovarian Research 2023 16:224
  13. Ovarian cancer is a significant public health concern with a poor prognosis for epithelial ovarian cancer. To explore the potential of immunotherapy in treating epithelial ovarian cancer, we investigated the i...

    Authors: Hua Yang, Xiangyu Gu, Rong Fan, Qun Zhu, Sen Zhong, Xirun Wan, Qian Chen, Lan Zhu and Fengzhi Feng
    Citation: Journal of Ovarian Research 2023 16:223
  14. The objective of this study is to investigate the effects of an ethanolic extract derived from Agaricus subrufescens on rat models exhibiting Polycystic Ovarian Syndrome (PCOS) induced by Letrozole.

    Authors: Sarad Pawar Naik Bukke, Bharghava Bhushan Rao Pathange, Srikanth Kumar Karumanchi, Jalaiah Marri, Revathi Boyina, Kavya Rachamsetty, Bhargavi Manchikalapati, Saidi Odoma and Bello Hussaini
    Citation: Journal of Ovarian Research 2023 16:221
  15. High-grade serous ovarian cancer (OvCa) is the most common type of epithelial OvCa. It is usually diagnosed in advanced stages, leaving a woman’s chance of survival below 50%. Despite traditional chemotherapeu...

    Authors: Melayshia McFadden, Santosh Kumar Singh, Briana Kinnel, Sooryanarayana Varambally and Rajesh Singh
    Citation: Journal of Ovarian Research 2023 16:220
  16. Angiogenesis and metastasis contributes substantially to the poor outcome of patients with ovarian cancer. We aimed to explore the role and mechanisms of the long non-coding RNA NEAT1 (nuclear enriched abundan...

    Authors: Yang Liu, Yan Li, Yanzhi Wu, Yiyue Zhao, Xi Hu and Chunyi Sun
    Citation: Journal of Ovarian Research 2023 16:219
  17. High-grade serous carcinoma (HGSC) is the most common and aggressive subtype of epithelial ovarian cancer, characterized by gain-of-function TP53 mutations originating in the fallopian tube epithelium. Therapeuti...

    Authors: Madison Pereira, Alice Glogova, Jacob Haagsma, Julia Stewart, Trevor G. Shepherd and Jim Petrik
    Citation: Journal of Ovarian Research 2023 16:218
  18. Authors: Xing‑Hua Pan, Xue‑Juan Zhang, Xiang Yao, Ni‑Ni Tian, Zai‑Ling Yang, Kai Wang, Xiang‑Qing Zhu, Jing Zhao, Jie He, Xue‑Min Cai, Rong‑Qing Pang and Guang‑Ping Ruan
    Citation: Journal of Ovarian Research 2023 16:217

    The original article was published in Journal of Ovarian Research 2021 14:133

  19. Women with polycystic ovary syndrome (PCOS) have higher intestinal mucosal permeability, leading to the lipopolysaccharide (LPS) leakage and endotoxemia. This, in turn, leads to oxidative stress (OS) and neuro...

    Authors: Negin Nikrad, Mahdieh Abbasalizad Farhangi, Fatemeh Pourteymour Fard Tabrizi, Maryam Vaezi, Ata Mahmoudpour and Mehran Mesgari-Abbasi
    Citation: Journal of Ovarian Research 2023 16:216
  20. Polycystic ovary syndrome (PCOS) is an endocrine disorder characterized by ovarian cysts, high androgen levels, and irregular menstruation. The causality between PCOS and breast cancer (BC) has been widely dis...

    Authors: Runxiang Cao, Lanlan Chen, Yutong Liu, Xuyutian Wang, Ruolin Ma, Qian Zhao and Ye Du
    Citation: Journal of Ovarian Research 2023 16:215
  21. No residual disease (CC 0) following cytoreductive surgery is pivotal for the prognosis of women with advanced stage epithelial ovarian cancer (EOC). Improving CC 0 resection rates without increasing morbidity...

    Authors: Diederick de Jong, Amudha Thangavelu, Timothy Broadhead, Inga Chen, Dermot Burke, Richard Hutson, Racheal Johnson, Angelika Kaufmann, Peter Lodge, David Nugent, Aaron Quyn, Georgios Theophilou and Alexandros Laios
    Citation: Journal of Ovarian Research 2023 16:214
  22. The oocyte cumulus complex is mainly composed of an oocyte, the perivitelline space, zona pellucida and numerous granulosa cells. The cumulus granulosa cells (cGCs) provide a particularly important microenviro...

    Authors: Chongyi Shu, Yiqi Yu, Xiaopan Chen, Jiansheng Guo, Yier Zhou, Dandan Wu, Tianyun Yang, Yuhang Fan, Qiongxiao Huang and Jing Shu
    Citation: Journal of Ovarian Research 2023 16:213
  23. To study whether CAG repeat polymorphism of androgen receptor (AR) contributes to the risk of polycystic ovarian morphology (PCOM) with antral follicle count (AFC) ≥ 20 in the context of new international guideli...

    Authors: Xueqi Yan, Xueying Gao, Qian Shang, Ziyi Yang, Yuteng Wang, Li Liu, Wei Liu, Dan Liu, Fang Cheng, Shigang Zhao, Han Zhao, Junli Zhao and Zi-Jiang Chen
    Citation: Journal of Ovarian Research 2023 16:211
  24. Premature ovarian insufficiency (POI) is a highly heterogeneous disease, and up to 25% of the cases can be explained by genetic causes. G protein-coupled receptor 3 (GPR3) plays an important role in oocyte arr...

    Authors: Shuting Ren, Feng Zhang, Lingyue Shang, Xi Yang, Yuncheng Pan, Xiaojin Zhang and Yanhua Wu
    Citation: Journal of Ovarian Research 2023 16:210
  25. The therapeutic effect of poly (ADP-ribose) polymerase inhibitors (PARPi) monotherapy compared with platinum-based chemotherapy, and the impact to subsequent platinum-based chemotherapy after PARPi resistance ...

    Authors: Yana Ma, Jiale Liu, Ning Li, Hualei Bu, Yongwen Huang, Chengjuan Jin, Hao Wen, Shuai Feng, Hui Zhang, Xiaorong Yang, Beihua Kong, Lingying Wu and Kun Song
    Citation: Journal of Ovarian Research 2023 16:209
  26. Polycystic ovary syndrome (PCOS) is the most common endocrinopathy associated with infertility and metabolic disorder in women of reproductive age. Animal models have been developed and used as tools to unrave...

    Authors: Haowen Wu, Bining Zhao, Qiyang Yao and Jihong Kang
    Citation: Journal of Ovarian Research 2023 16:207
  27. Follicular microenvironment has been proposed as an important factor for oocyte grown and maturation. We sought to evaluate the oxidative stress and inflammatory levels in follicular fluid (FF) and association...

    Authors: Yan Huang, Yi Cheng, Min Zhang, Yan Xia, Xiaoyan Chen, Yexing Xian, Dewei Lin, Suyan Xie and Xinyu Guo
    Citation: Journal of Ovarian Research 2023 16:206
  28. The immune system played a multifaceted role in ovarian cancer (OC) and was a significant mediator of ovarian carcinogenesis. Various immune cells and immune gene products played an integrated role in ovarian ...

    Authors: Hongjun Fei, Xu Han, Yanlin Wang and Shuyuan Li
    Citation: Journal of Ovarian Research 2023 16:205
  29. Studies have shown that supplementation with recombinant human GH (rh-GH) during ovarian stimulation (OS) may improve the ovarian response and clinical outcomes of IVF. However, it remains unclear whether GH i...

    Authors: Yilun Sui, Min Xiao, Jing Fu, Lu Li, Yining Xu, Caixia Lei and Xiaoxi Sun
    Citation: Journal of Ovarian Research 2023 16:204
  30. Premature ovarian insufficiency (POI) is an important cause of infertility characterized by the functional decline of the ovary. Granulosa cells (GCs) around oocytes are critical for folliculogenesis, and GC d...

    Authors: Dan Liu, Xiaohong Guan, Wenqiang Liu, Yanping Jia, Hong Zhou, Chenxiang Xi, Mei Zhao, Yuan Fang, Li Wu and Kunming Li
    Citation: Journal of Ovarian Research 2023 16:203
  31. Gynecologic cancers comprise malignancies in the female reproductive organs. Ovarian cancer ranks sixth in terms of incidence rates while seventh in terms of mortality rates. The stage at which ovarian cancer ...

    Authors: Khushbukhat Khan, Sameen Zafar, Yasmin Badshah, Naeem Mahmood Ashraf, Mehak Rafiq, Lubna Danish, Maria Shabbir, Janeen H. Trembley, Tayyaba Afsar, Ali Almajwal and Suhail Razak
    Citation: Journal of Ovarian Research 2023 16:202
  32. The factors affecting the cumulative live birth rate (CLBR) of PCOS (Polycystic ovary syndrom) patients who received in vitro fertilization/intracytoplasmic sperm injection-embryo transfer (IVF/ICSI-ET) needs ...

    Authors: You Li, Leizhen Xia, Zengming Li, Ziyu Zhang and Ru Jiang
    Citation: Journal of Ovarian Research 2023 16:201
  33. Patients with epithelial ovarian carcinoma (EOC) are usually diagnosed at an advanced stage with tumour cell invasion. However, identifying the underlying molecular mechanisms and biomarkers of EOC proliferati...

    Authors: Yuanfu Zhang, Shu Sun, Yue Qi, Yifan Dai, Yangyang Hao, Mengyu Xin, Rongji Xu, Hongyan Chen, Xiaoting Wu, Qian Liu, Congcong Kong, Guangmei Zhang, Peng Wang and Qiuyan Guo
    Citation: Journal of Ovarian Research 2023 16:200
  34. Premature ovarian failure (POF) is one of the leading causes of female infertility and is accompanied by abnormal endocrine, seriously affecting female quality of life. Previous studies have demonstrated that ...

    Authors: Wenjie Dai, Hong Yang, Bo Xu, Tiantian He, Ling Liu, Xiaoqian Ma, Jiaxue Ma, Guoqin Yang, Rui Si, Xiuying Pei, Xing Du and Xufeng Fu
    Citation: Journal of Ovarian Research 2023 16:198
  35. Whether pretreatment with gonadotropin-releasing hormone agonist (GnRHa) can improve the pregnancy outcomes in frozen-thawed embryo transfer (FET) cycles is controversial. The inconsistencies in the results of...

    Authors: Bin Xu, Zhaojuan Hou, Nenghui Liu, Jing Zhao and Yanping Li
    Citation: Journal of Ovarian Research 2023 16:197
  36. Ovarian cancer (OV) is the most fatal gynecological malignant tumor worldwide, with high recurrence rates and great heterogeneity. Pyroptosis is a newly-acknowledged inflammatory form of cell death with an ess...

    Authors: Jiani Yang, Chao Wang, Yue Zhang, Shanshan Cheng, Yanna Xu and Yu Wang
    Citation: Journal of Ovarian Research 2023 16:196
  37. Natural cycle- in vitro fertilization (NC-IVF) is particularly recommended for women with decreased ovarian reserve (DOR) or poor response to controlled ovarian hyperstimulation. In these cases, it can be chal...

    Authors: Tian Tian, Yu Li, Jiaxin Lv, Lixue Chen, Yuanyuan Wang, Rui Yang, Ping Liu, Rong Li and Jie Qiao
    Citation: Journal of Ovarian Research 2023 16:195
  38. The nuclear receptor subfamily 5 group A member 1 (NR5A1), encoding steroidogenic factor 1 (SF-1), has been identified as a critical factor in gonadal development in animal studies. A previous study of ours sugge...

    Authors: Laura Danti, Karolina Lundin, Kirsi Sepponen, Dawit A. Yohannes, Juha Kere, Timo Tuuri and Juha S. Tapanainen
    Citation: Journal of Ovarian Research 2023 16:194
  39. Evaluating the efficacy of letrozole overlapped with gonadotropin-modified letrozole protocol (mLP) for diminished ovarian reserve (DOR) or advanced-age women with repeated cycles.

    Authors: Xiaojia Li, Jingbo Chen, Yang Zhao, Fengyi He, Meijun Zeng, Guijun Guan and Xiaomiao Zhao
    Citation: Journal of Ovarian Research 2023 16:193
  40. The failure of frozen-thawed blastocysts to re-expand adequately within a few hours after warming has been reported to have a negative impact on assisted reproductive technology (ART) outcomes. However, the ex...

    Authors: Ayumo Ito, Yukiko Katagiri, Satoko Oigawa, Kenji Amano, Koichiro Ichizawa, Yukiko Tokuda, Mami Unagami, Masato Yoneyama, Takahiro Tsuchiya, Mami Sekiguchi, Mayuko Furui, Kentaro Nakaoka, Nahomi Umemura, Yuko Hayashi, Yuko Tamaki, Koichi Nagao…
    Citation: Journal of Ovarian Research 2023 16:192
  41. Recent studies have suggested a potential link between systemic inflammatory regulators and primary ovarian insufficiency (POI); however, a causal relationship between them remains unclear. In this study, we e...

    Authors: Jiahui Wang, Xia Zhao, Rong Luo, Di Xia, Yi Liu, Tao Shen and Yuanjiao Liang
    Citation: Journal of Ovarian Research 2023 16:191
  42. Because often introduced without proper validation studies, so-called “add-ons” to IVF have adversely affected in vitro fertilization (IVF) outcomes worldwide. All-freeze cycles (embryo banking, EB) with subse...

    Authors: Norbert Gleicher, Sarah K. Darmon, Pasquale Patrizio and David. H. Barad
    Citation: Journal of Ovarian Research 2023 16:190
  43. The concentration of human chorionic gonadotropin (hCG)/ luteinizing hormone (LH) after triggering is generally accepted as a predictor of the normal ovarian response to the trigger, but few studies have explo...

    Authors: Hao Jin, Haiyan Yang, Jiujia Zheng, Jiechun Zhou and Rong Yu
    Citation: Journal of Ovarian Research 2023 16:189
  44. Cancer cells may develop resistance to cisplatin by various mechanisms. Yet, the exact mechanism of cisplatin in ovarian cancer remains unclear. Recent studies have shown that 3’-phospoadenosine 5’-phosphosulf...

    Authors: Lei Sun, Wei-Xue Ji, Yan Li, Ze-Lian Li, Can-Can Duan, Bai-rong Xia and Lan Xiao
    Citation: Journal of Ovarian Research 2023 16:187
  45. Tumor-associated lncRNAs regulated by epigenetic modification switches mediate immune escape and chemoresistance in ovarian cancer (OC). However, the underlying mechanisms and concrete targets have not been sy...

    Authors: Lu Chen, Wujiang Gao, Li Lin, Chunli Sha, Taoqiong Li, Qi Chen, Hong Wei, Meiling Yang, Jie Xing, Mengxue Zhang, Shijie Zhao, Wenlin Xu, Yuefeng Li, Lulu Long and Xiaolan Zhu
    Citation: Journal of Ovarian Research 2023 16:186

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2022 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    149 days submission to accept (Median)

    2022 Usage 
    744 Altmetric mentions